Search for: "MedImmune, Inc. v. Genentech, Inc." Results 81 - 100 of 153
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Dec 2011, 2:50 pm by Matt Osenga
Did the court of appeals err in adopting a new and inflexible rule, contrary to normal standing rules and this Court’s decision in MedImmune, Inc. v. [read post]
8 Jul 2011, 1:37 pm by SteinMcewen, LLP
Significance for Patent Owners Finding mechanisms to contact potential licensees has been problematic after MedImmune, Inc. v. [read post]
21 Aug 2008, 9:43 pm
  Following the Federal Circuit's decision in Teva Pharmaceuticals USA, Inc. v. [read post]
12 Dec 2011, 1:37 pm by Rantanen
Genentech, Inc., 549 U.S. 118 (2007)….? [read post]
8 Dec 2009, 12:33 pm by Matt Osenga
The court noted that the Supreme Court’s decision in MedImmune, Inc. v. [read post]
19 Oct 2007, 4:10 am
 The Court, therefore, relied upon the Supreme Court’s recent MedImmune, Inc. v. [read post]
29 Oct 2013, 7:42 am by Ronald Mann
The case follows directly from the Court’s 2007 reversal of the Federal Circuit in MedImmune, Inc. v. [read post]
8 Sep 2016, 11:29 am by Dennis Crouch
The leading precedent actual-controversy precedent for patent cases is the Supreme Court’s 2007 decision in MedImmune, Inc. v. [read post]
11 Mar 2015, 9:40 am by Dennis Crouch
MercExchange, L.L.C., 547 U.S. 388 (2006) (injunctive relief) MedImmune, Inc. v. [read post]
3 Mar 2009, 2:43 pm
Genentech,  Inc., 549 U.S. 1163 (2007); and extended the patent exhaustion doctrine in Quanta Computer, Inc. [read post]